Physician profile
Gregorio Jacob
NPI 1558325811
$3,465.69
in general payments reported to CMS, 2019-2025
43 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,122 · 2020: $581 · 2021: $1,018 · 2022: $727 · 2023: $17.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $670.64 | 2019-2022 | |
| Novo Nordisk INC | $247.02 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $222.91 | 2019-2022 | |
| Preventric Diagnostics, INC. | $199.95 | 2021 | |
| Lilly USA, LLC | $186.61 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $174.84 | 2019-2022 | |
| Glaxosmithkline, LLC. | $162.89 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $138.54 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $128.43 | 2019-2022 | |
| Abbvie INC. | $125.56 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $120.34 | 2019-2022 | |
| Janssen Biotech, INC. | $106.68 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $92.88 | 2019-2022 | |
| Akcea Therapeutics, INC. | $87.84 | 2019 | |
| Merck Sharp & Dohme LLC | $71.66 | 2020-2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregorio Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.